Despite prompt epicardial recanalization in patients presenting with ST-segment elevation
myocardial infarction (STEMI), coronary microvascular obstruction and dysfunction (CMVO) …

Oral antiplatelet drugs are crucially important for patients with acute coronary syndrome or
stable coronary artery disease undergoing percutaneous coronary intervention (PCI). In …

Background Guidelines recommend adjunct glycoprotein IIb/IIIa inhibitors (GPIs) only in
selected patients with acute ST-segment elevation myocardial infarction (STEMI). This study …

abstract Timely and effective antithrombotic therapy is critical to improving outcome,
including survival, in patients with acute coronary syndrome (ACS). Achieving effective …

Background Intracoronary (IC) administration of glycoprotein IIb/IIIa inhibitors (GPIs) has
been studied as an adjunctive therapy to improve outcomes in patients with ST-segment …

Several randomized trials have demonstrated the benefits of an invasive strategy for older
patients with acute coronary syndromes (ACS); however, there are limited real-world data of …

Background The role of targeted hypothermia in patients with coma after cardiac arrest has
been challenged in a recent randomized clinical trial. Methods We performed a …

Background: To determine whether intracoronary pro-urokinase or tirofiban improves
myocardial reperfusion during primary percutaneous coronary intervention (PCI) for acute …

To investigate the potential effect of intracoronary administration of the glycoprotein IIb/IIIa
inhibitor tirofiban on the microvascular obstruction (MVO) assessed by cardiac magnetic …

BACKGROUND: This study investigated the effects of the intracoronary injection of
nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients …